"CLL expert Dr. John Pagel, from Seattle Cancer Care Alliance, highlights exciting data from the 2013 American Society of Hematology (ASH) annual meeting. Dr. Pagel discusses why he believes that this is the best time in CLL, as a variety of new drugs become available, even for high-risk patients. He speaks about the “new and improved monoclonal antibodies,” the role of chemotherapy and details some of the blockbuster studies giving patients far more options than ever before." - See more at: patientpower.info/video/tre...
Last edited by HAIRBEAR
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.